Profit taking sinks Cellectar Biosciences

Investors locked in profits on Cellectar Biosciences Inc. (Nasdaq: CLRB). The stock price plunged 92 cents to close at $3.15.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.